Biotechnology Stocks
459 Aktien verfolgt in Biotechnology
| Ticker | Unternehmen | Marktkapit. | P/E | Signale |
|---|---|---|---|---|
| AAPG | Ascentage Pharma Group International - American Depository Shares | $19.4B | — | — |
| ABBV | AbbVie Inc. Common Stock | $433.0B | 119.1 | — |
| ABEO | Abeona Therapeutics Inc. - Common Stock | $406.1M | 6.1 | — |
| ABOS | Acumen Pharmaceuticals, Inc. - Common Stock | $175.5M | — | — |
| ABSI | Absci Corporation - Common Stock | $1.5B | — | — |
| ABUS | Arbutus Biopharma Corporation - Common Stock | $837.6M | — | — |
| ABVC | ABVC BioPharma, Inc. - Common Stock | $51.8M | — | — |
| ABVX | Abivax SA - American Depositary Shares | $9.4B | — | — |
| ACAD | ACADIA Pharmaceuticals Inc. - Common Stock | $5.0B | 13.2 | 3 |
| ACET | Adicet Bio, Inc. - Common Stock | $74.7M | — | — |
| ACHV | Achieve Life Sciences, Inc. - Common Shares | $563.1M | — | — |
| ACIU | AC Immune SA - Common Stock | $234.6M | — | — |
| ACOG | Alpha Cognition Inc. - Common Stock | $192.7M | — | — |
| ACRV | Acrivon Therapeutics, Inc. - Common Stock | $70.6M | — | — |
| ACTU | Actuate Therapeutics, Inc. - Common stock | $62.1M | — | — |
| ACXP | Acurx Pharmaceuticals, Inc. - Common Stock | $8.0M | — | — |
| ADAG | Adagene Inc. - ADS, each representing 1.25 ordinary shares | $89.1M | — | — |
| ADCT | ADC Therapeutics SA Common Shares | $143.7M | — | — |
| ADMA | ADMA Biologics Inc - Common Stock | $2.2B | 13.1 | 2 |
| AGEN | Agenus Inc. - Common Stock | $311.5M | 4.8 | — |
| AGIO | Agios Pharmaceuticals, Inc. - Common Stock | $1.8B | — | — |
| AIXC | AIxCrypto Holdings, Inc. - Common Stock | $12.1M | — | — |
| AKBA | Akebia Therapeutics, Inc. - Common Stock | $346.1M | — | — |
| AKTX | Akari Therapeutics Plc - American Depositary Shares | $4.0M | — | — |
| ALDX | Aldeyra Therapeutics, Inc. - Common Stock | $93.5M | — | — |
| ALEC | Alector, Inc. - Common Stock | $197.6M | — | — |
| ALGS | Aligos Therapeutics, Inc. - Common stock | $29.3M | — | — |
| ALKS | Alkermes plc - Ordinary Shares | $8.5B | 55.9 | 1 |
| ALLO | Allogene Therapeutics, Inc. - Common Stock | $716.2M | — | — |
| ALLR | Allarity Therapeutics, Inc. - Common stock | $21.4M | — | — |
| ALNY | Alnylam Pharmaceuticals, Inc. - Common Stock | $28.9B | 50.1 | — |
| ALPS | ALPS Group Inc - Ordinary Share | $144.7M | — | — |
| ALT | Altimmune, Inc. - Common Stock | $586.1M | — | — |
| ALVO | Alvotech - Ordinary Shares | $1.6B | — | — |
| ALXO | ALX Oncology Holdings Inc. - Common Stock | $282.6M | — | — |
| ALZN | Alzamend Neuro, Inc. - Common Stock | $6.9M | — | — |
| AMGN | Amgen Inc. - Common Stock | $204.9B | 26.3 | 6 |
| AMRN | Amarin Corporation plc - American Depositary Shares | $297.0M | — | — |
| ANAB | AnaptysBio, Inc. - Common Stock | $1.8B | — | — |
| ANIK | Anika Therapeutics Inc. - Common Stock | $261.7M | — | — |
| ANIX | Anixa Biosciences, Inc. - Common Stock | $96.6M | — | — |
| ANL | Adlai Nortye Ltd. - American Depositary Shares | $52.4M | — | — |
| ANNX | Annexon, Inc. - common stock | $846.7M | — | — |
| ANVS | Annovis Bio, Inc. Common Stock | $71.1M | — | — |
| APGE | Apogee Therapeutics, Inc. - Common Stock | $10.2B | — | — |
| APLM | Apollomics Inc. - Class A Ordinary Shares | $20.6M | — | — |
| APRE | Aprea Therapeutics, Inc. - Common Stock | $11.1M | — | — |
| APVO | Aptevo Therapeutics Inc. - Common Stock | $5.8M | — | — |
| AQB | AquaBounty Technologies, Inc. - Common Stock | $3.6M | — | — |
| ARCT | Arcturus Therapeutics Holdings Inc. - Common Stock | $210.6M | — | — |
| ARDX | Ardelyx, Inc. - Common Stock | $1.2B | — | — |
| ARGX | argenx SE - American Depositary Shares | $44.1B | 33.8 | — |
| ARQT | Arcutis Biotherapeutics, Inc. - Common stock | $3.3B | — | — |
| ARTV | Artiva Biotherapeutics, Inc. - Common Stock | $552.5M | — | — |
| ARWR | Arrowhead Pharmaceuticals, Inc. - Common Stock | $12.5B | — | — |
| ASMB | Assembly Biosciences, Inc. - Common Stock | $472.6M | — | — |
| ASND | Ascendis Pharma A/S - American Depositary Shares | $12.8B | — | — |
| ATHE | Alterity Therapeutics Limited - American Depositary Shares | $87.0M | — | — |
| ATOS | Atossa Therapeutics, Inc. - Common Stock | $23.5M | — | — |
| ATRA | Atara Biotherapeutics, Inc. - Common Stock | $86.3M | 2.6 | — |
| ATYR | aTyr Pharma, Inc. - Common Stock | $51.5M | — | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | $2.0B | 6.7 | 2 |
| AURA | Aura Biosciences, Inc. - Common Stock | $800.2M | — | — |
| AUTL | Autolus Therapeutics plc - American Depositary Shares | $550.9M | — | — |
| AVBP | ArriVent BioPharma, Inc. - Common Stock | $1.3B | — | — |
| AVTX | Avalo Therapeutics, Inc. - Common Stock | $1.0B | — | — |
| AVXL | Anavex Life Sciences Corp. - Common Stock | $318.1M | — | — |
| BBIO | BridgeBio Pharma, Inc. - Common Stock | $16.6B | — | — |
| BBLG | Bone Biologics Corp - Common Stock | $2.3M | — | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. - Common Stock | $632.1M | 134.0 | — |
| BCAB | BioAtla, Inc. - Common Stock | $33.5M | — | — |
| BCAX | Bicara Therapeutics Inc. - Common Stock | $1.8B | — | — |
| BCDA | BioCardia, Inc. - Common Stock | $14.2M | — | — |
| BCRX | BioCryst Pharmaceuticals, Inc. - Common Stock | $2.3B | — | — |
| BCTX | BriaCell Therapeutics Corp. - Common Shares | $18.5M | — | — |
| BCYC | Bicycle Therapeutics plc - American Depositary Shares | $275.1M | — | — |
| BDRX | Biodexa Pharmaceuticals plc - American Depositary Shares | $1.4M | — | — |
| BDTX | Black Diamond Therapeutics, Inc. - Common Stock | $112.0M | — | — |
| BEAM | Beam Therapeutics Inc. - Common Stock | $2.8B | — | — |
| BGMS | Bio Green Med Solution, Inc. - Common Stock | $7.3M | — | — |
| BHVN | Biohaven Ltd. Common Shares | $2.2B | — | — |
| BIAF | bioAffinity Technologies, Inc. - Common Stock | $5.3M | — | — |
| BIIB | Biogen Inc. - Common Stock | $31.8B | 23.2 | 2 |
| BIVI | BioVie Inc. - Common stock | $8.7M | — | — |
| BLRX | BioLineRx Ltd. - American Depositary Shares | $41.8M | — | — |
| BMEA | Biomea Fusion, Inc. - Common Stock | $91.3M | — | — |
| BMRN | BioMarin Pharmaceutical Inc. - Common Stock | $11.6B | 43.0 | 3 |
| BNR | Burning Rock Biotech Limited - American Depositary Shares | $216.9M | — | — |
| BNTC | Benitec Biopharma Inc. - Common Stock | $431.5M | — | — |
| BNTX | BioNTech SE - American Depositary Shares | $23.3B | — | 4 |
| BOLD | Boundless Bio, Inc. - Common Stock | $63.1M | — | — |
| BOLT | Bolt Biotherapeutics, Inc. - Common Stock | $9.2M | — | — |
| BRNS | Barinthus Biotherapeutics plc - American Depositary Shares | $23.1M | — | — |
| BRTX | BioRestorative Therapies, Inc. - Common Stock | $4.9M | — | — |
| BTAI | BioXcel Therapeutics, Inc. - Common Stock | $30.9M | — | — |
| BYSI | BeyondSpring, Inc. - Ordinary Shares | $57.6M | — | — |
| CABA | Cabaletta Bio, Inc. - Common Stock | $451.3M | — | — |
| CADL | Candel Therapeutics, Inc. - Common Stock | $642.4M | — | — |
| CAI | Caris Life Sciences, Inc. - Common Stock | $6.4B | 61.1 | — |
| CAMP | CAMP4 Therapeutics Corporation - Common Stock | $231.6M | — | — |
| CAPR | Capricor Therapeutics, Inc. - Common Stock | $252.5M | — | — |
| CBIO | Crescent Biopharma, Inc. - Common Stock | $164.8M | — | — |
| CBUS | Cibus, Inc. - Class A Common Stock | $148.5M | — | — |
| CCCC | C4 Therapeutics, Inc. - Common Stock | $185.1M | — | — |
| CDIO | Cardio Diagnostics Holdings Inc. - Common stock | $4.9M | — | — |
| CDNA | CareDx, Inc. - Common Stock | $2.5B | — | — |
| CELC | Celcuity Inc. - Common Stock | $4.4B | — | — |
| CELU | Celularity Inc. - Class A Common Stock | $27.6M | — | — |
| CELZ | Creative Medical Technology Holdings, Inc. - Common Stock | $6.7M | — | — |
| CGEM | Cullinan Therapeutics, Inc. - Common Stock | $1.1B | — | — |
| CGEN | Compugen Ltd. - Ordinary Shares | $226.5M | 6.5 | — |
| CGON | CG Oncology, Inc. - Common stock | $6.6B | — | — |
| CHRS | Coherus Oncology, Inc. - Common Stock | $223.7M | 1.2 | — |
| CLDX | Celldex Therapeutics, Inc. - Common Stock | $3.3B | — | — |
| CLGN | CollPlant Biotechnologies Ltd. - Ordinary Shares | $17.8M | — | — |
| CLLS | Cellectis S.A. - American Depositary Shares | $303.4M | — | — |
| CLNN | Clene Inc. - Common Stock | $84.1M | — | — |
| CLRB | Cellectar Biosciences, Inc. - Common Stock | $13.1M | — | — |
| CLYM | Climb Bio, Inc. - Common Stock | $846.0M | — | — |
| CMMB | Chemomab Therapeutics Ltd. - American Depositary Shares | $12.2M | — | — |
| CMPS | COMPASS Pathways Plc - American Depository Shares | $1.6B | — | — |
| CMPX | Compass Therapeutics, Inc. - Common Stock | $387.2M | — | — |
| CNTB | Connect Biopharma Holdings Limited - Ordinary Shares | $148.0M | — | — |
| COGT | Cogent Biosciences, Inc. - Common Stock | $5.9B | — | — |
| COYA | Coya Therapeutics, Inc. - Common Stock | $116.3M | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $185.1M | — | — |
| CRBU | Caribou Biosciences, Inc. - Common Stock | $159.7M | — | — |
| CRDF | Cardiff Oncology, Inc. - Common Stock | $114.2M | — | — |
| CRIS | Curis, Inc. - Common Stock | $12.8M | — | — |
| CRSP | CRISPR Therapeutics AG - Common Shares | $5.2B | — | — |
| CRVO | CervoMed Inc. - Common Stock | $45.4M | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. - Common Stock | $1.1B | — | — |
| CTMX | CytomX Therapeutics, Inc. - Common Stock | $733.7M | — | — |
| CTOR | Citius Oncology, Inc. - Common Stock | $70.0M | — | — |
| CUE | Cue Biopharma, Inc. - Common Stock | $27.9M | — | — |
| CYCN | Cyclerion Therapeutics, Inc. - Common Stock | $5.0M | — | — |
| CYPH | Cypherpunk Technologies Inc. - Common Stock | $65.7M | — | — |
| CYTK | Cytokinetics, Incorporated - Common Stock | $10.0B | — | — |
| DBVT | DBV Technologies S.A. - American Depositary Shares | $678.3M | — | — |
| DMAC | DiaMedica Therapeutics Inc. - Common Stock | $353.7M | — | — |
| DNLI | Denali Therapeutics Inc. - Common Stock | $3.9B | — | — |
| DNTH | Dianthus Therapeutics, Inc. - Common Stock | $6.2B | — | — |
| DRMA | Dermata Therapeutics, Inc. - Common Stock | $4.5M | — | — |
| DRUG | Bright Minds Biosciences Inc. - common stock | $859.9M | — | — |
| DSGN | Design Therapeutics, Inc. - Common Stock | $875.5M | — | — |
| DTIL | Precision BioSciences, Inc. - Common Stock | $205.1M | — | — |
| DWTX | Dogwood Therapeutics, Inc. - Common Stock | $62.1M | — | — |
| DYAI | Dyadic International, Inc. - Common Stock | $28.4M | — | — |
| DYN | Dyne Therapeutics, Inc. - Common Stock | $4.7B | — | — |
| EBS | Emergent BioSolutions Inc. Common Stock | $231.2M | — | — |
| EDIT | Editas Medicine, Inc. - Common Stock | $442.3M | — | — |
| EDSA | Edesa Biotech, Inc. - Common Shares | $53.1M | — | — |
| ELDN | Eledon Pharmaceuticals, Inc. - Common Stock | $293.3M | — | — |
| ELTX | Elicio Therapeutics, Inc. - Common Stock | $182.7M | — | — |
| ELUT | Elutia, Inc. - Class A Common Stock | $37.5M | 0.8 | — |
| ENGN | enGene Holdings Inc. - Common Stock | $116.6M | — | — |
| ENLV | Enlivex Therapeutics Ltd. - Ordinary Shares | $17.1M | — | — |
| ENSC | Ensysce Biosciences, Inc. - Common Stock | $2.6M | — | — |
| ENTA | Enanta Pharmaceuticals, Inc. - Common Stock | $400.4M | — | — |
| ENTX | Entera Bio Ltd. - Ordinary Shares | $142.9M | — | — |
| EPRX | Eupraxia Pharmaceuticals Inc. - Common Stock | $522.7M | — | — |
| EQ | Equillium, Inc. - Common Stock | $146.1M | — | — |
| ERAS | Erasca, Inc. - Common Stock | $3.2B | — | — |
| ERNA | Ernexa Therapeutics Inc. - Common Stock | $7.3M | — | — |
| ESLA | Estrella Immunopharma, Inc. - Common Stock | $58.9M | — | — |
| EVAX | Evaxion A/S - American Depositary Share | $26.8M | — | — |
| EVGN | Evogene Ltd. - Ordinary Shares | $10.6M | — | — |
| EVMN | Evommune, Inc. Common Stock | $964.2M | — | — |
| EXEL | Exelixis, Inc. - Common Stock | $13.6B | 16.3 | 4 |
| EXOZ | eXoZymes Inc. - Common Stock | $91.4M | — | — |
| FATE | Fate Therapeutics, Inc. - Common Stock | $317.0M | — | — |
| FBIO | Fortress Biotech, Inc. - Common Stock | $102.3M | 0.8 | — |
| FBIOP | Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | $113.6M | 28.5 | — |
| FBLG | FibroBiologics, Inc. - Common Stock | $5.3M | — | — |
| FBRX | Forte Biosciences, Inc. - Common Stock | $1.6B | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. - Common Stock | $544.7M | — | — |
| FENC | Fennec Pharmaceuticals Inc. - Common Stock | $384.9M | — | — |
| FHTX | Foghorn Therapeutics Inc. - Common Stock | $370.6M | — | — |
| GALT | Galectin Therapeutics Inc. - Common Stock | $142.8M | — | — |
| GANX | Gain Therapeutics, Inc. - Common Stock | $74.6M | — | — |
| GDTC | CytoMed Therapeutics Limited - Ordinary Shares | $15.7M | — | — |
| GERN | Geron Corporation - Common Stock | $997.6M | — | — |
| GILD | Gilead Sciences, Inc. - Common Stock | $163.2B | 17.7 | 6 |
| GLMD | Galmed Pharmaceuticals Ltd. - Ordinary Shares | $4.1M | — | — |
| GLSI | Greenwich LifeSciences, Inc. - Common stock | $326.6M | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. - Common Stock | $1.3B | — | — |
| GMAB | Genmab A/S - American Depositary Shares | $124.8B | 13.3 | 3 |
| GNLX | Genelux Corporation - Common Stock | $130.0M | — | — |
| GNPX | Genprex, Inc. - Common Stock | $7.8M | — | — |
| GNTA | Genenta Science S.p.A. - American Depositary Shares | $28.5M | — | — |
| GOSS | Gossamer Bio, Inc. - Common Stock | $79.8M | — | — |
| GOVX | GeoVax Labs, Inc. - Common Stock | $5.3M | — | — |
| GRAL | GRAIL, Inc. - Common Stock | $3.0B | — | — |
| GRDX | GridAI Technologies Corp. - Common Stock | $28.6M | — | — |
| GRFS | Grifols, S.A. - American Depositary Shares | $6.5B | 17.5 | — |
| GRI | GRI Bio, Inc. - Common Stock | $3.3M | — | — |
| GTBP | GT Biopharma, Inc. - Common Stock | $12.4M | — | — |
| GYRE | Gyre Therapeutics, Inc. - Common Stock | $736.9M | — | — |
| HALO | Halozyme Therapeutics, Inc. - Common Stock | $11.8B | 28.5 | 4 |
| HCWB | HCW Biologics Inc. - Common Stock | $9.0M | — | — |
| HOWL | Werewolf Therapeutics, Inc. - Common Stock | $30.8M | — | — |
| HRTX | Heron Therapeutics, Inc. - Common Stock | $92.9M | — | — |
| HUMA | Humacyte, Inc. - Common Stock | $200.7M | — | — |
| HURA | TuHURA Biosciences, Inc. - Common Stock | $147.1M | — | — |
| IBIO | iBio, Inc. - Common Stock | $43.4M | — | — |
| IBRX | ImmunityBio, Inc. - Common Stock | $7.9B | — | — |
| ICCC | ImmuCell Corporation - Common Stock | $100.4M | — | — |
| IDYA | IDEAYA Biosciences, Inc. - Common Stock | $3.6B | — | — |
| IFRX | InflaRx N.V. - Common Stock | $261.4M | — | — |
| IKT | Inhibikase Therapeutics, Inc. - Common Stock | $253.5M | — | — |
| IMCR | Immunocore Holdings plc - American Depositary Shares | $1.7B | — | — |
| IMDX | Insight Molecular Diagnostics Inc. - Common Stock | $157.6M | — | — |
| IMMP | Immutep Limited - American Depositary Shares | $611.6M | — | — |
| IMMX | Immix Biopharma, Inc. - Common Stock | $692.0M | — | — |
| IMNM | Immunome, Inc. - Common Stock | $2.6B | — | — |
| IMNN | Imunon, Inc. - Common Stock | $6.8M | — | — |
| IMRN | Immuron Limited - American Depositary Shares | $11.8M | — | — |
| IMRX | Immuneering Corporation - Class A Common Stock | $293.1M | — | — |
| IMTX | Immatics N.V. - Ordinary Shares | $1.5B | — | — |
| IMUX | Immunic, Inc. - Common Stock | $162.1M | — | — |
| IMVT | Immunovant, Inc. - Common Stock | $8.2B | — | — |
| INAB | IN8bio, Inc. - Common Stock | $9.6M | — | — |
| INBX | Inhibrx Biosciences, Inc. - Common Stock | $1.6B | — | — |
| INCY | Incyte Corporation - Common Stock | $23.9B | 16.7 | 3 |
| INDP | Indaptus Therapeutics, Inc. - Common Stock | $5.1M | — | — |
| INKT | MiNK Therapeutics, Inc. - Common Stock | $54.6M | — | — |
| INMB | INmune Bio Inc. - Common stock | $55.3M | — | — |
| INO | Inovio Pharmaceuticals, Inc. - Common Stock | $109.4M | — | — |
| INSM | Insmed Incorporated - Common Stock | $28.4B | — | — |
| INTS | Intensity Therapeutics, Inc. - Common Stock | $13.2M | — | — |
| IONS | Ionis Pharmaceuticals, Inc. - Common Stock | $8.8B | — | — |
| IOVA | Iovance Biotherapeutics, Inc. - Common Stock | $2.7B | — | — |
| IPHA | Innate Pharma S.A. - American Depositary Shares | $147.7M | — | — |
| IPSC | Century Therapeutics, Inc. - Common Stock | $411.2M | — | — |
| IRD | Opus Genetics, Inc. - Common Stock | $304.5M | — | — |
| IRON | Disc Medicine, Inc. - Common Stock | $3.0B | — | — |
| IRWD | Ironwood Pharmaceuticals, Inc. - Class A Common Stock | $695.5M | 6.8 | — |
| IVA | Inventiva S.A. - American Depository Shares | $753.5M | — | — |
| IVVD | Invivyd, Inc. - Common Stock | $415.7M | — | — |
| JANX | Janux Therapeutics, Inc. - Common Stock | $1.0B | — | — |
| JBIO | Jade Biosciences, Inc. - Common Stock | $709.8M | — | — |
| JSPR | Jasper Therapeutics, Inc. - Class A Common Stock | $23.8M | — | — |
| KALA | KALA BIO, Inc. - Common Stock | $12.2M | — | — |
| KLRS | Kalaris Therapeutics, Inc. - Common Stock | $102.6M | — | — |
| KMDA | Kamada Ltd. - Ordinary Shares | $412.5M | 20.3 | 1 |
| KNSA | Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $4.9B | 66.9 | — |
| KOD | Kodiak Sciences Inc - Common Stock | $2.2B | — | — |
| KPTI | Karyopharm Therapeutics Inc. - Common Stock | $46.0M | — | — |
| KROS | Keros Therapeutics, Inc. - common stock | $209.0M | — | — |
| KRRO | Korro Bio, Inc. - Common Stock | $195.7M | — | — |
| KRYS | Krystal Biotech, Inc. - Common Stock | $9.7B | 43.0 | — |
| KTTA | Pasithea Therapeutics Corp. - Common Stock | $19.5M | — | — |
| KURA | Kura Oncology, Inc. - Common Stock | $915.3M | — | — |
| KYMR | Kymera Therapeutics, Inc. - Common Stock | $8.9B | — | — |
| KYTX | Kyverna Therapeutics, Inc. - Common Stock | $576.9M | — | — |
| KZIA | Kazia Therapeutics Limited - American Depositary Shares | $11.5M | — | — |
| LEGN | Legend Biotech Corporation - American Depositary Shares | $3.8B | — | — |
| LGVN | Longeveron Inc. - Class A Common stock | $23.3M | — | — |
| LIMN | Liminatus Pharma, Inc. - Class A Common Stock | $16.5M | — | — |
| LITS | Lite Strategy, Inc. - Common Stock | $48.6M | — | — |
| LNAI | Lunai Bioworks Inc. - Common Stock | $20.7M | — | — |
| LRMR | Larimar Therapeutics, Inc. - Common Stock | $416.6M | — | — |
| LSTA | Lisata Therapeutics, Inc. - Common Stock | $16.4M | — | — |
| LTRN | Lantern Pharma Inc. - Common Stock | $34.2M | — | — |
| LXEO | Lexeo Therapeutics, Inc. - Common Stock | $399.7M | — | — |
| LYEL | Lyell Immunopharma, Inc. - Common Stock | $360.5M | — | — |
| MBIO | Mustang Bio, Inc. - Common Stock | $7.2M | — | — |
| MBRX | Moleculin Biotech, Inc. - Common Stock | $11.3M | — | — |
| MCRB | Seres Therapeutics, Inc. - Common Stock | $48.0M | — | — |
| MDCX | Medicus Pharma Ltd. - Common Stock | $16.6M | — | — |
| MDGL | Madrigal Pharmaceuticals, Inc. - Common Stock | $11.9B | — | — |
| MDXG | MiMedx Group, Inc - Common Stock | $602.0M | 19.6 | 2 |
| MDXH | MDxHealth SA - Ordinary Shares | $22.9M | — | — |
| MENS | Jyong Biotech Ltd. - Ordinary shares | $300.3M | — | — |
| MESO | Mesoblast Limited - American Depositary Shares | $3.5B | — | — |
| MGNX | MacroGenics, Inc. - Common Stock | $210.4M | — | — |
| MGTX | MeiraGTx Holdings plc - Ordinary Shares | $870.0M | — | — |
| MGX | Metagenomi Therapeutics, Inc. - Common Stock | $49.3M | — | — |
| MIRM | Mirum Pharmaceuticals, Inc. - common stock | $5.7B | — | — |
| MLTX | MoonLake Immunotherapeutics - Class A Ordinary Shares | $1.2B | — | — |
| MLYS | Mineralys Therapeutics, Inc. - Common Stock | $2.3B | — | 1 |
| MNKD | MannKind Corporation - Common Stock | $1.3B | — | 1 |
| MNOV | MediciNova, Inc. - Common Stock | $67.9M | — | — |
| MNPR | Monopar Therapeutics Inc. - Common Stock | $396.6M | — | — |
| MOLN | Molecular Partners AG - American Depositary Shares | $136.7M | — | — |
| MPLT | MapLight Therapeutics, Inc. - Common Stock | $1.2B | — | — |
| MREO | Mereo BioPharma Group plc - American Depositary Shares | $38.6M | — | — |
| MRKR | Marker Therapeutics, Inc. - Common Stock | $23.7M | — | — |
| MRNA | Moderna, Inc. - Common Stock | $21.9B | — | — |
| MTVA | MetaVia Inc. - Common Stock | $9.6M | — | — |
| MYGN | Myriad Genetics, Inc. - Common Stock | $291.7M | — | — |
| NAMS | NewAmsterdam Pharma Company N.V. - Ordinary Shares | $3.3B | — | — |
| NBIX | Neurocrine Biosciences, Inc. - Common Stock | $17.1B | 24.2 | 5 |
| NBP | NovaBridge Biosciences - American Depositary Shares | $458.9M | — | — |
| NBTX | Nanobiotix S.A. - ADSs | $943.5M | — | — |
| NCEL | NewcelX Ltd. - Ordinary Shares | $8.7M | — | — |
| NCNA | NuCana plc - American Depositary Shares | $14.7M | — | — |
| NERV | Minerva Neurosciences, Inc - Common Stock | $198.9M | — | — |
| NEUP | Neuphoria Therapeutics Inc. - Common Stock | $20.7M | — | — |
| NGNE | Neurogene Inc. - Common Stock | $471.2M | — | — |
| NKTX | Nkarta, Inc. - Common Stock | $176.0M | — | — |
| NNNN | Anbio Biotechnology - Class A Ordinary Shares | $4.3B | 724.8 | — |
| NRIX | Nurix Therapeutics, Inc. - Common stock | $2.4B | — | — |
| NRSN | NeuroSense Therapeutics Ltd. - Ordinary Shares | $22.8M | — | — |
| NTLA | Intellia Therapeutics, Inc. - Common Stock | $1.5B | — | — |
| NTRA | Natera, Inc. - Common Stock | $38.2B | — | — |
| NVAX | Novavax, Inc. - Common Stock | $1.3B | — | — |
| NVCT | Nuvectis Pharma, Inc. - Common Stock | $615.0M | — | — |
| NXTC | NextCure, Inc. - Common Stock | $23.8M | — | — |
| OCGN | Ocugen, Inc. - Common Stock | $434.1M | — | — |
| OKUR | OnKure Therapeutics, Inc. - Class A Common Stock | $157.9M | — | — |
| OKYO | OKYO Pharma Limited - Ordinary Shares | $77.9M | — | — |
| OLMA | Olema Pharmaceuticals, Inc. - Common Stock | $1.0B | — | — |
| ONC | BeOne Medicines Ltd. - American Depositary Shares | $261.0B | — | — |
| ONCO | Onconetix, Inc. - Common Stock | $2.4M | — | — |
| ONCY | Oncolytics Biotech Inc. - Common Shares | $142.7M | — | — |
| ORGO | Organogenesis Holdings Inc. - Class A | $240.6M | 88.5 | — |
| ORIC | Oric Pharmaceuticals, Inc. - Common Stock | $1.4B | — | — |
| ORKA | Oruka Therapeutics, Inc. - Common Stock | $7.1B | — | — |
| OSRH | OSR Holdings, Inc. - Common Stock | $14.5M | — | — |
| OTLK | Outlook Therapeutics, Inc. - Common Stock | $163.2M | — | — |
| OVID | Ovid Therapeutics Inc. - Common Stock | $451.7M | — | — |
| PALI | Palisade Bio, Inc. - Common Stock | $361.9M | — | — |
| PASG | Passage Bio, Inc. - Common Stock | $14.1M | — | — |
| PBM | Psyence Biomedical Ltd. - Common Shares | $1.4M | 5.5 | — |
| PBYI | Puma Biotechnology Inc - Common Stock | $424.0M | 17.4 | — |
| PCVX | Vaxcyte, Inc. - Common Stock | $8.7B | — | 1 |
| PDSB | PDS Biotechnology Corporation - Common Stock | $40.1M | — | — |
| PEPG | PepGen Inc. - Common Stock | $197.1M | — | — |
| PGEN | Precigen, Inc. - Common Stock | $2.6B | — | — |
| PHAR | Pharming Group N.V. - ADS, each representing 10 ordinary shares | $977.0M | 11475.5 | — |
| PHIO | Phio Pharmaceuticals Corp. - Common Stock | $12.5M | — | — |
| PLRZ | Polyrizon Ltd. - Ordinary Shares | $13.5M | — | — |
| PLUR | Pluri Inc. - Common Stock | $27.7M | — | — |
| PMCB | PharmaCyte Biotech, Inc. - Common Stock | $7.3M | — | — |
| PMN | ProMIS Neurosciences Inc. - Common Shares | $132.6M | — | — |
| PMVP | PMV Pharmaceuticals, Inc. - Common Stock | $74.1M | — | — |
| PPCB | Propanc Biopharma, Inc. - Common Stock | $7.2M | — | — |
| PRAX | Praxis Precision Medicines, Inc. - Common Stock | $8.9B | — | — |
| PRLD | Prelude Therapeutics Incorporated - Common Stock | $302.4M | — | — |
| PRME | Prime Medicine, Inc. - Common Stock | $556.3M | — | — |
| PROK | ProKidney Corp. - Class A Ordinary Shares | $501.3M | — | — |
| PRQR | ProQR Therapeutics N.V. - Ordinary Shares | $212.5M | — | — |
| PRTA | Prothena Corporation plc - Ordinary Shares | $449.2M | — | — |
| PTCT | PTC Therapeutics, Inc. - Common Stock | $5.7B | — | 1 |
| PTGX | Protagonist Therapeutics, Inc. - Common Stock | $9.6B | 115.4 | 2 |
| PURR | Hyperliquid Strategies Inc - Common Stock | — | — | — |
| PVLA | Palvella Therapeutics, Inc. - Common Stock | $2.2B | — | — |
| PYXS | Pyxis Oncology, Inc. - Common Stock | $143.3M | — | — |
| QNCX | Quince Therapeutics, Inc. - Common Stock | $20.2M | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. - American Depositary Shares | $9.5M | — | — |
| QTTB | Q32 Bio Inc. - Common Stock | $468.3M | 15.7 | — |
| QURE | uniQure N.V. - Ordinary Shares | $1.7B | — | — |
| RADX | Radiopharm Theranostics Limited - American Depositary Shares | $88.6M | — | — |
| RARE | Ultragenyx Pharmaceutical Inc. - Common Stock | $2.5B | — | — |
| RCEL | Avita Medical, Inc. - Common Stock | $137.6M | — | — |
| RCKT | Rocket Pharmaceuticals, Inc. - Common Stock | $393.6M | — | — |
| RCUS | Arcus Biosciences, Inc. Common Stock | $3.7B | — | — |
| REGN | Regeneron Pharmaceuticals, Inc. - Common Stock | $73.7B | 16.7 | 1 |
| REPL | Replimune Group, Inc. - Common Stock | $762.5M | — | — |
| REVB | Revelation Biosciences, Inc. - Common Stock | $4.4M | — | — |
| RGNX | REGENXBIO Inc. - Common Stock | $729.5M | — | — |
| RIGL | Rigel Pharmaceuticals, Inc. - Common Stock | $763.8M | 2.1 | — |
| RLAY | Relay Therapeutics, Inc. - Common Stock | $4.3B | — | — |
| RLYB | Rallybio Corporation - Common Stock | $75.8M | — | — |
| RNA | Avidity Biosciences, Inc. - Common Stock | $226.4M | — | — |
| RNAC | Cartesian Therapeutics, Inc. - Common Stock | $262.0M | — | — |
| RNAZ | TransCode Therapeutics, Inc. - Common Stock | $6.3M | — | — |
| RNTX | Rein Therapeutics, Inc. - Common Stock | $29.4M | — | — |
| RNXT | RenovoRx, Inc. - Common Stock | $52.3M | — | — |
| ROIV | Roivant Sciences Ltd. - Common Shares | $21.5B | — | — |
| RVMD | Revolution Medicines, Inc. - Common Stock | $44.5B | — | — |
| RXRX | Recursion Pharmaceuticals, Inc. - Class A Common Stock | $1.8B | — | — |
| RYTM | Rhythm Pharmaceuticals, Inc. - Common Stock | $7.1B | — | — |
| RZLT | Rezolute, Inc. - Common Stock (NV) | $218.8M | — | — |
| SABS | SAB Biotherapeutics, Inc. - Common Stock | $288.3M | 21.7 | — |
| SANA | Sana Biotechnology, Inc. - Common Stock | $1.0B | — | — |
| SBFM | Sunshine Biopharma Inc. - Common stock | $3.2M | — | — |
| SCNI | Scinai Immunotherapeutics Ltd. - American Depositary Shares | $612K | 0.1 | — |
| SERA | Sera Prognostics, Inc. - Class A Common Stock | $78.7M | — | — |
| SGMT | Sagimet Biosciences Inc. - Series A Common Stock | $407.5M | — | — |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. - common stock | $2.9M | — | — |
| SILO | Silo Pharma, Inc. - Common Stock | $4.5M | — | — |
| SION | Sionna Therapeutics, Inc. - Common Stock | $295.7M | — | — |
| SKYE | Skye Bioscience, Inc. - Common Stock | $28.6M | — | — |
| SLDB | Solid Biosciences Inc. - Common Stock | $826.0M | — | — |
| SLN | Silence Therapeutics Plc - American Depository Share | $287.2M | — | — |
| SLS | SELLAS Life Sciences Group, Inc. - Common Stock | $1.3B | — | — |
| SLXN | Silexion Therapeutics Corp - Ordinary Shares | $1.2M | — | — |
| SMMT | Summit Therapeutics Inc. - Common Stock | $11.9B | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. - Common Stock | $1.7B | — | — |
| SNGX | Soligenix, Inc. - Common Stock | $5.3M | — | — |
| SNTI | Senti Biosciences, Inc. - Common Stock | $31.5M | — | — |
| SPRB | Spruce Biosciences, Inc. - Common Stock | $127.2M | — | — |
| SPRO | Spero Therapeutics, Inc. - Common Stock | $72.1M | 4.7 | — |
| SPRY | ARS Pharmaceuticals, Inc. - Common Stock | $605.7M | — | — |
| SRPT | Sarepta Therapeutics, Inc. - Common Stock | $1.8B | 27.2 | — |
| SRRK | Scholar Rock Holding Corporation - Common Stock | $6.3B | — | — |
| SRZN | Surrozen, Inc. - Common Stock | $297.5M | — | — |
| STOK | Stoke Therapeutics, Inc. - Common Stock | $2.1B | — | 1 |
| STRO | Sutro Biopharma, Inc. - Common Stock | $645.7M | — | — |
| STTK | Shattuck Labs, Inc. - Common Stock | $538.3M | — | — |
| SVA | Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) | $639.9M | — | — |
| SVRA | Savara, Inc. - Common Stock | $1.0B | — | — |
| SYRE | Spyre Therapeutics, Inc. - Common Stock | $9.3B | — | — |
| TARA | Protara Therapeutics, Inc. - Common Stock | $275.2M | — | — |
| TCRT | Alaunos Therapeutics, Inc. - Common Stock | $7.2M | — | — |
| TCRX | TScan Therapeutics, Inc. - Common Stock | $75.7M | — | — |
| TECX | Tectonic Therapeutic, Inc. - Common Stock | $685.0M | — | — |
| TENX | Tenax Therapeutics, Inc. - Common Stock | $503.0M | — | — |
| TGTX | TG Therapeutics, Inc. - Common Stock | $7.1B | 16.0 | 2 |
| TIL | Instil Bio, Inc. - Common Stock | $54.7M | — | — |
| TLSA | Tiziana Life Sciences Ltd - Common Shares | $177.1M | — | — |
| TLSI | TriSalus Life Sciences, Inc. - Common Stock | $344.5M | — | — |
| TNGX | Tango Therapeutics, Inc. - Common Stock | $3.7B | — | — |
| TNXP | Tonix Pharmaceuticals Holding Corp. - Common Stock | $191.8M | — | — |
| TNYA | Tenaya Therapeutics, Inc. - Common Stock | $165.3M | — | — |
| TPST | Tempest Therapeutics, Inc. - Common Stock | $26.2M | — | — |
| TRDA | Entrada Therapeutics, Inc. - Common Stock | $270.6M | — | — |
| TSHA | Taysha Gene Therapies, Inc. - Common Stock | $1.9B | — | — |
| TVGN | Tevogen Bio Holdings Inc. - Common Stock | $65.8M | — | — |
| TVTX | Travere Therapeutics, Inc. - Common Stock | $5.3B | — | — |
| TWST | Twist Bioscience Corporation - Common Stock | $1.9B | — | — |
| TYRA | Tyra Biosciences, Inc. - Common Stock | $1.6B | — | — |
| UNCY | Unicycive Therapeutics, Inc. - Common Stock | $224.7M | — | — |
| UPB | Upstream Bio, Inc. - Common Stock | $478.4M | — | — |
| URGN | UroGen Pharma Ltd. - Ordinary Shares | $1.9B | — | — |
| UTHR | United Therapeutics Corporation - Common Stock | $22.0B | 17.1 | 1 |
| VALN | Valneva SE - American Depositary Shares | $639.8M | — | — |
| VCEL | Vericel Corporation - Common Stock | $2.4B | 97.6 | — |
| VCYT | Veracyte, Inc. - Common Stock | $3.6B | 31.5 | — |
| VERA | Vera Therapeutics, Inc. - Class A Common Stock | $3.5B | — | — |
| VIR | Vir Biotechnology, Inc. - Common Stock | $1.5B | — | — |
| VIVS | VivoSim Labs, Inc. - Common Stock | $4.7M | — | — |
| VKTX | Viking Therapeutics, Inc. - Common Stock | $3.7B | — | 1 |
| VNDA | Vanda Pharmaceuticals Inc. - Common Stock | $312.6M | — | — |
| VOR | Vor Biopharma Inc. - Common Stock | $816.7M | — | — |
| VRDN | Viridian Therapeutics, Inc. - Common Stock | $2.5B | — | — |
| VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | $121.1B | 27.5 | 4 |
| VSTM | Verastem, Inc. - Common Stock | $519.3M | — | — |
| VTGN | Vistagen Therapeutics, Inc. - Common Stock | $22.8M | — | — |
| VTVT | vTv Therapeutics Inc. - Class A Common Stock | $139.3M | 61.9 | — |
| VYGR | Voyager Therapeutics, Inc. - Common Stock | $197.6M | — | — |
| WHWK | Whitehawk Therapeutics, Inc. - Common Stock | $256.0M | — | — |
| XBIO | Xenetic Biosciences, Inc. - Common Stock | $5.0M | — | — |
| XBIT | XBiotech Inc. - Common Stock | $72.9M | — | — |
| XCUR | Exicure, Inc. - Common Stock | $34.5M | — | — |
| XENE | Xenon Pharmaceuticals Inc. - Common Shares | $6.1B | — | — |
| XFOR | X4 Pharmaceuticals, Inc. - Common Stock | $393.3M | — | — |
| XGN | Exagen Inc. - Common Stock | $109.4M | — | — |
| XLO | Xilio Therapeutics, Inc. - Common Stock | $45.5M | — | — |
| XNCR | Xencor, Inc. - Common Stock | $1.5B | — | — |
| XTLB | XTL Biopharmaceuticals Ltd. - American Depositary Shares | — | — | — |
| YDES | YD Bio Limited - Ordinary Shares | $859.7M | — | — |
| ZBIO | Zenas BioPharma, Inc. - Common Stock | $1.1B | — | — |
| ZLAB | Zai Lab Limited - American Depositary Shares | $15.3B | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. - common stock | $300.4M | — | — |
| ZURA | Zura Bio Limited - Class A Ordinary shares | $488.8M | — | — |
| ZYME | Zymeworks Inc. - Common Stock | $1.6B | — | — |
Keine Aktien entsprechen Ihren Filtern
Versuchen Sie, Ihre Suchkriterien anzupassen
Weitere Aktien werden geladen...